论文部分内容阅读
目的观察盐酸氨溴索雾化吸入辅助治疗新生儿感染性肺炎的临床效果。方法将新生儿感染性肺炎100例随机分为观察组53例和对照组47例,对照组患儿在综合治疗基础上应用α-糜蛋白酶雾化吸入,观察组患儿在综合治疗基础上应用盐酸氨溴索雾化吸入。比较2组临床效果及症状、体征消失时间。结果观察组治疗显效率和总有效率均高于对照组,差异有统计学意义(P<0.05)。观察组患儿症状、体征消失时间均早于对照组,住院时间短于对照组,差异有统计学意义(P<0.05)。结论盐酸氨溴索雾化吸入辅助治疗新生儿感染性肺炎效果显著,起效快,能够较快改善症状、体征,缩短住院时间,值得应用。
Objective To observe the clinical effect of inhalation of ambroxol hydrochloride inhalation on neonatal pneumonia. Methods One hundred cases of neonatal pneumonia were randomly divided into observation group (n = 53) and control group (n = 47). Patients in the control group were treated with inhalation of α-chymotrypsin on the basis of comprehensive treatment. The observation group was treated on the basis of comprehensive treatment Ambroxol Hydrochloride inhalation. The clinical effects and symptoms were compared between the two groups, and the signs disappeared. Results The effective rate and total effective rate of observation group were higher than that of the control group, the difference was statistically significant (P <0.05). The symptoms and signs disappeared in the observation group earlier than the control group, and the length of stay in the observation group was shorter than that of the control group (P <0.05). Conclusion Ambroxol Hydrochloride inhalation is an effective adjuvant treatment of neonatal pneumonia due to its rapid onset, rapid improvement of symptoms and signs, and shorter hospital stay, which is worthy of application.